Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Gift boosts efforts to understand and combat rare cancers

Gift boosts efforts to understand and combat rare cancers

Adaptive cognitive training program can benefit children with sickle cell disease

Adaptive cognitive training program can benefit children with sickle cell disease

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

New grant to Harvard Medical School is boosting efforts to understand and combat rare cancers

New grant to Harvard Medical School is boosting efforts to understand and combat rare cancers

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

New AI-based decision support system can help prevent anemia in hemodialysis patients

New AI-based decision support system can help prevent anemia in hemodialysis patients

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders

Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls

Pfizer’s newest vaccine plant has persistent mold issues, history of recalls

Transmission risk for schistosomiasis peaks at higher water temperature

Transmission risk for schistosomiasis peaks at higher water temperature

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

Despite modest progress, maternal and child undernutrition remains a key health concern

Despite modest progress, maternal and child undernutrition remains a key health concern

A single letter difference in a single gene spells a lifetime of anemia, pain worldwide

A single letter difference in a single gene spells a lifetime of anemia, pain worldwide

'Miracle poison' can target a variety of different proteins

'Miracle poison' can target a variety of different proteins

Microfluidic chip and AI-powered automated microscope help measure hemoglobin levels

Microfluidic chip and AI-powered automated microscope help measure hemoglobin levels

Scientists examine DNA repair pathways and their impact on cancer evolution

Scientists examine DNA repair pathways and their impact on cancer evolution

Researchers develop non-cereal crop to enhance yields and consumer health

Researchers develop non-cereal crop to enhance yields and consumer health

Delayed time between abnormal stool-based screening and colonoscopy increases cancer risk

Delayed time between abnormal stool-based screening and colonoscopy increases cancer risk

Study: TALEN is five times more efficient than CRISPR-Cas9 in tightly packed DNA

Study: TALEN is five times more efficient than CRISPR-Cas9 in tightly packed DNA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.